Lenskart Solutions Limited (NSE:LENSKART)
513.95
+15.45 (3.10%)
At close: May 22, 2026
Lenskart Solutions Revenue
In the fiscal year ending March 31, 2026, Lenskart Solutions had annual revenue of 88.14B INR with 32.49% growth. Lenskart Solutions had revenue of 25.16B in the quarter ending March 31, 2026, with 45.62% growth.
Revenue
88.14B
Revenue Growth
+32.49%
P/S Ratio
10.13
Revenue / Employee
4.85M
Employees
18,173
Market Cap
892.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 88.14B | 21.62B | 32.49% |
| Mar 31, 2025 | 66.53B | 12.25B | 22.57% |
| Mar 31, 2024 | 54.28B | 16.38B | 43.23% |
| Mar 31, 2023 | 37.89B | 22.87B | 152.17% |
| Mar 31, 2022 | 15.03B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Aurobindo Pharma | 331.82B |
| Cipla | 277.12B |
| Zydus Lifesciences | 271.48B |
| Apollo Hospitals Enterprise | 252.29B |
| Biocon | 169.27B |
| Glenmark Pharmaceuticals | 165.10B |
| Mankind Pharma | 142.78B |
Lenskart Solutions News
- 4 days ago - Lenskart Solutions Quarterly report: Q4 2026 - Filings
- 4 days ago - Lenskart Solutions Transcript: Q4 25/26 - Transcripts
- 4 days ago - Lenskart Solutions Transcript: Q4 25/26 - Transcripts
- 4 days ago - Lenskart Solutions Quarterly report: Q4 2026 - Filings
- 3 months ago - Lenskart Solutions Transcript: Q3 25/26 - Transcripts
- 3 months ago - Lenskart Solutions Shareholder letter: Q3 2026 - Filings
- 3 months ago - Lenskart Solutions Quarterly report: Q3 2026 - Filings
- 3 months ago - Lenskart Solutions Transcript: Q3 25/26 - Transcripts